Evidence map›Paper›PMID 34220749›Full record

ArticleFrontiers in microbiology2021

Effects of Ribosomal Protein S10 Flexible Loop Mutations on Tetracycline and Tigecycline Susceptibility of

Norbert Izghirean, Claudia Waidacher, Clemens Kittinger, Miriam Chyba, Günther Koraimann, Brigitte Pertschy, Gernot Zarfel

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Norbert IzghireanDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Claudia WaidacherDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Clemens KittingerDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Miriam ChybaDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Günther KoraimannInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Brigitte PertschyInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Gernot ZarfelDiagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
University of Graz · ATMedical University of Graz · AT

Funding

Austrian Science Fund FWF P 32320
6 · The paper itself

Abstract

Tigecycline is a tetracycline derivative that is being used as an antibiotic of last resort. Both tigecycline and tetracycline bind to the small (30S) ribosomal subunit and inhibit translation. Target mutations leading to resistance to these antibiotics have been identified both in the 16S ribosomal RNA and in ribosomal proteins S3 and S10 (encoded by the

Indexed as

16S rRNAhelix 31ribosomal protein S10rpsJtetracyclinetigecycline

Identifiers

PMID34220749
PMCPMC8249722
OpenAlexW3175645813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.